ITMI20030827A1 - Composizione farmaceutica contenente l'associazione levodopa/carbidopa. - Google Patents

Composizione farmaceutica contenente l'associazione levodopa/carbidopa.

Info

Publication number
ITMI20030827A1
ITMI20030827A1 IT000827A ITMI20030827A ITMI20030827A1 IT MI20030827 A1 ITMI20030827 A1 IT MI20030827A1 IT 000827 A IT000827 A IT 000827A IT MI20030827 A ITMI20030827 A IT MI20030827A IT MI20030827 A1 ITMI20030827 A1 IT MI20030827A1
Authority
IT
Italy
Prior art keywords
carbidopa
levodopa
association
pharmaceutical composition
composition containing
Prior art date
Application number
IT000827A
Other languages
English (en)
Inventor
Alessandro Tagliamonte
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Priority to IT000827A priority Critical patent/ITMI20030827A1/it
Priority to US10/553,388 priority patent/US20070042037A1/en
Priority to JP2006505023A priority patent/JP2006523633A/ja
Priority to PCT/EP2004/003669 priority patent/WO2004091588A1/en
Priority to CNA2004800102828A priority patent/CN1774240A/zh
Priority to EP04725908A priority patent/EP1615627A1/en
Publication of ITMI20030827A1 publication Critical patent/ITMI20030827A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IT000827A 2003-04-18 2003-04-18 Composizione farmaceutica contenente l'associazione levodopa/carbidopa. ITMI20030827A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT000827A ITMI20030827A1 (it) 2003-04-18 2003-04-18 Composizione farmaceutica contenente l'associazione levodopa/carbidopa.
US10/553,388 US20070042037A1 (en) 2003-04-18 2004-04-06 Pharmaceutical composition containing levodopa and carbidopa
JP2006505023A JP2006523633A (ja) 2003-04-18 2004-04-06 レボドーパ及びカルビドーパを含む医薬組成物
PCT/EP2004/003669 WO2004091588A1 (en) 2003-04-18 2004-04-06 Pharmaceutical composition containing levodopa and carbidopa
CNA2004800102828A CN1774240A (zh) 2003-04-18 2004-04-06 含有左旋多巴和卡比多巴的药物组合物
EP04725908A EP1615627A1 (en) 2003-04-18 2004-04-06 Pharmaceutical composition containing levodopa and carbidopa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000827A ITMI20030827A1 (it) 2003-04-18 2003-04-18 Composizione farmaceutica contenente l'associazione levodopa/carbidopa.

Publications (1)

Publication Number Publication Date
ITMI20030827A1 true ITMI20030827A1 (it) 2004-10-19

Family

ID=33187378

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000827A ITMI20030827A1 (it) 2003-04-18 2003-04-18 Composizione farmaceutica contenente l'associazione levodopa/carbidopa.

Country Status (6)

Country Link
US (1) US20070042037A1 (it)
EP (1) EP1615627A1 (it)
JP (1) JP2006523633A (it)
CN (1) CN1774240A (it)
IT (1) ITMI20030827A1 (it)
WO (1) WO2004091588A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA95954C2 (ru) * 2006-05-31 2011-09-26 Солвей Фармасьютикалс Гмбх Продолжительное 24-часовое введение в кишечник леводопа/карбидопа
EP2105133A1 (en) * 2007-01-15 2009-09-30 Kissei Pharmaceutical Co., Ltd. Intragastric floating-type levodopa sustained-release preparation
WO2016186968A1 (en) * 2015-05-15 2016-11-24 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating motor disorders
CN105362252A (zh) * 2015-10-09 2016-03-02 北京万全德众医药生物技术有限公司 一种含有左旋多巴和卡比多巴的缓释胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US6756056B2 (en) * 1997-04-08 2004-06-29 Alan A. Rubin Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa
IL143899A0 (en) * 1998-12-24 2002-04-21 Janssen Pharmaceutica Nv Controlled release galantamine composition
AU2002325192B2 (en) * 2001-07-06 2008-05-22 Veloxis Pharmaceuticals, Inc. Controlled agglomeration
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms

Also Published As

Publication number Publication date
EP1615627A1 (en) 2006-01-18
WO2004091588A1 (en) 2004-10-28
US20070042037A1 (en) 2007-02-22
JP2006523633A (ja) 2006-10-19
CN1774240A (zh) 2006-05-17

Similar Documents

Publication Publication Date Title
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
DE60325255D1 (de) Duftzusammensetzung
DK2308855T3 (da) 2,4-Diaminopyrimidinderivater
FI20011478A (fi) Farmaseuttinen koostumus
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
FI20022128A (fi) Farmaseuttinen koostumus
FI20031042A0 (fi) Puristusmekanismi
ITMI20030827A1 (it) Composizione farmaceutica contenente l'associazione levodopa/carbidopa.
ES1051506Y (es) Juguete de composicion.
ITMI20031025A1 (it) Composizione d'inchiostro.
ITTO20020747A1 (it) Composizione.
FR2861290B1 (fr) Composition cosmetique thermogonflante.
ITTO20020745A1 (it) Composizione.
FR2842420B1 (fr) Composition cosmetique comprenant de l'ubiquitine
ITTO20030078A1 (it) Composizioni in particolare per l'impiego con elastomeri.
FR2852042B1 (fr) Piece d'aretier
ITAP20030005A1 (it) L'indimenticabile soluzione
ITMC20020044A1 (it) "composizione polimerica per la bricchettatura".
ES1050698Y (es) Cerramiento perfeccionado.
NO20033536D0 (no) Snus-porsjonerer
NO20034826D0 (no) Bokholder'n
ITLU20020007U1 (it) "calendario-libro"
NO20042803L (no) 1,3-diarylprop-2en-1-oner, preparater inneholdende forbindelsene samt anvendelse derav
ITPT20030007U1 (it) "mybox"